191A — MIMOSA Co Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for MIMOSA Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Tanshin |
Standards: | JAS | JAS | — |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 12,761 | 13,928 | 14,966 |
Cost of Revenue | |||
Gross Profit | 1,322 | 1,270 | 1,571 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Other Operating Expenses | |||
Total Operating Expenses | 12,593 | 13,878 | 14,814 |
Operating Profit | 168 | 50.3 | 152 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 219 | 221 | 384 |
Provision for Income Taxes | |||
Net Income After Taxes | 175 | 152 | 262 |
Net Income Before Extraordinary Items | |||
Net Income | 175 | 152 | 262 |
Adjustments to Net Income | |||
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 175 | 152 | 262 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 266 | 227 | 386 |
Dividends per Share |